SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech firesales
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (3228)3/30/2017 10:48:55 AM
From: tuck   of 3661
 
Corbus (CRBP) off 15% now on "positive" CF trial data. Positive data could just as easily have been background therapy of Vertex drugs, and events #s tiny. No lung function data supplied. Adam F. talks of imbalances in the arms. The company's scleroderma data were equivocal, but good enough to goose the stock. Harder to argue against Adam this time. I sold the scleroderma data, too, and I don't regret it. Not a buying opportunity, IMO.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News